Item Details

Examining Issues Related to Competition in the Pharmaceutical Marketplace: A Review of the FTC Report, Generic Drug Entry Prior to Patent Expiration : Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, Second Session, October 9, 2002

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Format
Book; Government Document; Online; EBook
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], 2002.
Language
English
Variant Title
Generic drug entry prior to patent expiration
ISBN
0160694779
SuDoc Number
Y 4.C 73/8:107-140
Description
iii, 142 p. ; 24 cm.
Mode of access: Internet.
Notes
  • "Serial no. 107-140."
  • Shipping list no.: 2003-0102-P.
  • Distributed to some depository libraries in microfiche.
  • Includes bibliographical references.
Logo for No Copyright - United StatesNo Copyright - United States
Technical Details

  • LEADER 02232cam a2200481Ia 4500
    001 012403913
    003 MiAaHDL
    005 20130605000000.0
    006 m d
    007 cr bn ---auaua
    008 030130s2002 dcu b f000 0 eng d
    020
      
      
    a| 0160694779
    035
      
      
    a| sdr-pst.a2369861
    035
      
      
    a| (OCoLC)51543393
    035
      
      
    a| tmp97312022
    040
      
      
    a| FTC c| FTC d| GPO d| MvI d| OCoLC
    043
      
      
    a| n-us---
    074
      
      
    a| 1019-B-01 (MF)
    074
      
      
    a| 1019-A-01
    086
    0
      
    a| Y 4.C 73/8:107-140
    088
      
      
    a| Serial no. 107-140 (United States. Congress. House. Committee on Energy and Commerce)
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Energy and Commerce. b| Subcommittee on Health.
    245
    1
    0
    a| Examining issues related to competition in the pharmaceutical marketplace : b| a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.
    246
    1
    0
    a| Generic drug entry prior to patent expiration
    260
      
      
    a| Washington : b| U.S. G.P.O. : b| For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], c| 2002.
    300
      
      
    a| iii, 142 p. ; c| 24 cm.
    500
      
      
    a| "Serial no. 107-140."
    500
      
      
    a| Shipping list no.: 2003-0102-P.
    500
      
      
    a| Distributed to some depository libraries in microfiche.
    504
      
      
    a| Includes bibliographical references.
    538
      
      
    a| Mode of access: Internet.
    610
    1
    0
    a| United States. b| Federal Trade Commission. t| Generic drug entry prior to patent expiration.
    650
      
    0
    a| Pharmaceutical industry z| United States.
    650
      
    0
    a| Competition z| United States.
    650
      
    0
    a| Drugs z| United States v| Patents.
    650
      
    0
    a| Generic drugs x| Government policy z| United States.
    974
      
      
    b| PST c| PST d| 20170116 s| google u| pst.000050189243 z| 4.C 73/8:107-140 y| 2002 r| pd q| bib

Access online

Google Preview